Allogene Therapeutics | DEFA14A: Others
Apr 24 04:38
Allogene Therapeutics | DEF 14A: Definitive information statements
Apr 24 04:38
Allogene Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 15 05:31
Allogene Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Mar 15 05:25
Allogene Therapeutics | 8-K: Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
Mar 15 04:17
Allogene Therapeutics | 8-K: Current report
Feb 16 21:31
Allogene Therapeutics | 8-K: Current report
Feb 1 02:48
Allogene Therapeutics | 8-K: Current report
Jan 5 13:00
Allogene Therapeutics | 8-K: Current report
Dec 20, 2023 04:46
Allogene Therapeutics | 8-K: Allogene Therapeutics Reports Third Quarter 2023 Financial Results and Business Update
Nov 3, 2023 04:03
Allogene Therapeutics | 8-K/A: Current report (Amendment)
Oct 18, 2023 04:34
Allogene Therapeutics | 8-K: Current report
Oct 16, 2023 20:31
Allogene Therapeutics | 8-K: Allogene Therapeutics Reports Second Quarter 2023 Financial Results and Business Update
Aug 3, 2023 04:04
Allogene Therapeutics | 8-K: Current report
Jun 22, 2023 04:05
Allogene Therapeutics | 8-K: Current report
Jun 16, 2023 04:08
Allogene Therapeutics | 8-K: Current report
Jun 14, 2023 20:04
Allogene Therapeutics | 8-K: Current report
Jun 8, 2023 04:16
Allogene Therapeutics | 8-K: Allogene Therapeutics Reports First Quarter 2023 Financial Results and Business Update
May 4, 2023 04:05
Allogene Therapeutics | DEFA14A: Others
Apr 25, 2023 04:09
Allogene Therapeutics | DEF 14A: Definitive proxy statements
Apr 25, 2023 04:06
No Data
No Data